All Industries

Top Life Sciences Companies

1,069 Life Sciences companies, sorted by total funding raised.

AvalynIPO

Avalyn Pharma develops inhaled formulations of approved medicines to improve treatment benefits a...

Boston, United States11–50Biotech, Healthcare
Series DTotal funding$372.5MJul 2025
Tilly

Tilly pairs autism-care and special education professionals with children while providing softwar...

Miami, United States51–200Healthcare, SaaS
Series BTotal funding$364.0MOct 2021
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series CTotal funding$363.0MJan 2025
Dewpoint Therapeutics

Biotech company applying biomolecular condensate science to drug discovery across oncology, neuro...

Boston, United States51–200Life Sciences, Biotech
Series DTotal funding$346.1MSep 2025
Cadence

Cadence helps health systems deliver continuous chronic care through clinical AI, remote monitori...

New York, United States201–500Life Sciences, Healthcare
Series CTotal funding$344.0MJun 2026
MF
Motif FoodWorksClosed

Motif FoodWorks is a synthetic biology company that designs and sells ingredients to companies th...

Boston, United States11–50Life Sciences
Series BTotal funding$343.5MJun 2021
MEGAROBO

MEGAROBO provides autonomous agents and multi-agent robotics solutions that help businesses autom...

Beijing, China201–500Robotics, Life Sciences
Series CTotal funding$342.3MJun 2022
Redesign Health

Venture and applied-technology firm that builds and funds healthcare startups, partnering with fo...

New York, United States51–200Life Sciences, Artificial Intelligence
Venture RoundTotal funding$340.0MDec 2024
Seaport Therapeutics

Seaport Therapeutics is a clinical-stage biopharmaceutical company developing neuropsychiatric me...

Boston, United States11–50Life Sciences
GrantTotal funding$340.0MMar 2026
Solve Therapeutics

Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates...

Belmont, United States11–50Life Sciences, Biotech
Series BTotal funding$321.0MNov 2025
Zenas BioPharmaIPO

Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...

Boston, United States51–200Biotech, Healthcare
Series CTotal funding$318.0MMay 2024
ArriVentIPO

Clinical-stage biopharma developing and commercializing oncology therapeutics, partnering to glob...

Newtown Square, United States11–50Biotech, Healthcare
Series BTotal funding$305.0MMar 2023
Arbor Biotechnologies

Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS ...

Cambridge, United States51–200Biotech, Drug Discovery
Series CTotal funding$304.5MMar 2025
Valo Health

AI-enabled biotechnology company using large-scale human data and computation to accelerate drug ...

Boston, United States51–200Artificial Intelligence, Biotech
Series BTotal funding$300.0MMar 2021
Octant Bio

Small molecule correctors for protein misfolding, enabled by a synthetic biology, high throughput...

Los Angeles, United States51–200Healthcare, Biotech
Series CTotal funding$290.2MOct 2025
BenchSci

AI-powered platform that accelerates drug discovery by helping pharmaceutical researchers find th...

Toronto, Canada201–500Artificial Intelligence, Drug Discovery
Series DTotal funding$265.2MMay 2023
FibroGenIPO

Develops novel therapeutics in oncology and anemia, advancing antibody-drug conjugates and HIF-PH...

San Francisco, United States11–50Biotech, Life Sciences
Venture RoundTotal funding$261.5MNov 2022
Kronos BioAcquired

Clinical-stage biopharma developing small‑molecule therapeutics targeting deregulated transcripti...

San Mateo, United States1–10Biotech, Healthcare
Series BTotal funding$260.0MAug 2020
Harbor Health

Austin-based primary and specialty clinic group that provides integrated care and clinician-desig...

Austin, United States201–500Life Sciences, Healthcare
Series BTotal funding$258.0MSep 2025
Alpha-9 Oncology

Clinical-stage radiopharmaceutical company developing differentiated and highly targeted radiopha...

Vancouver, CanadaLife Sciences, Biotech
Series CTotal funding$257.8MOct 2024
Frontier Medicines

Clinical-stage precision-medicine biotech using chemoproteomics and AI to discover covalent small...

San Francisco, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$255.5MJun 2024
SonderMind

Technology-driven behavioral health platform connecting individuals with therapists and mental he...

Denver, United States201–500Healthcare, Life Sciences
Venture RoundTotal funding$255.0MJan 2025
PathAI

PathAI develops AI-powered precision pathology solutions that analyze tissue samples, helping pat...

Boston, United States201–500Artificial Intelligence, Biotech
Series CTotal funding$251.0MMay 2021
Vir

Clinical-stage biopharmaceutical company leveraging the immune system to develop medicines for in...

San Francisco, United States201–500Biotech, Healthcare
Growth EquityTotal funding$250.0MOct 2024
InventisBioIPO

InventisBio develops clinical-stage medicines for oncology, autoimmune diseases, and metabolic di...

Shanghai, China11–50Biotech, Life Sciences
Series DTotal funding$247.0MSep 2020